We have rolled out a new QMS software solution that is now used companywide – MasterControl turns our culture of quality into an operational reality. We have an improved cloud-based electronic document management system that connects application, documentation, and data… Read More
Imaging Endpoints is a team of diverse and driven professionals with a goal to change the world by Connecting Imaging to the Cure. We embrace our differences and cherish all of our brothers and sisters in humanity. That is who… Read More
Forma Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced recently that the company’s investigational IDH1m inhibitor, olutasidenib, demonstrated a preliminary disease control rate of 50% in heavily pre-treated patients with predominantly enhancing, recurrent mIDH1… Read More
Scottsdale, Arizona, May 27, 2020 – Imaging Endpoints announced today that it has supported two additional U.S. Food and Drug Administration (FDA) approvals this month for new, life-saving therapies. The two New Drug Application (NDA) approvals, for two of the… Read More
Whether it is tumor blood flow, tumor microenvironment, or radiomics, Imaging Endpoints is at the leading edge of imaging science and is redefining the role an imaging core lab can provide in product development. It is one more way that… Read More
Radiomics is a rapidly growing field of radiology that extracts high-dimensional data from standard of care CT images to define a novel set of quantifiable imaging patterns – an imaging biomarker. Imaging Endpoints is a pioneer and global leader in… Read More
Imaging Endpoints has a great work environment and is leading the industry in our novel imaging technology. If you are looking for a position with great benefits and great opportunity to advance at the fastest-growing company in the imaging CRO… Read More
Imaging Endpoints’ COVID-19 analysis supports the detection and standardized recording of the clinical and radiological disease features consistent with the course of COVID-19 infection as well as the relevant epidemiological disease history. This data-driven approach offers a systematic means to… Read More
Imaging Endpoints has launched a whole new look online. Visit our new website at https://imagingendpoints.com/ and learn about all of our exciting and comprehensive novel imaging services.
Imaging Endpoints’ novel radiomic imaging technology has identified a potentially useful biomarker to non-invasively evaluate DKK1 expression according to updated clinical data presented by Leap Therapeutics Inc. The findings come from a recently completed Phase 1/2 clinical trial of DKN-01… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
